Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Lojewski, who is General Manager of North America, will serve on the industry group, which represents leading global biopharm…
CSL locations invited children ages 10-13 for a day of hands-on experiences at CSL Behring and CSL Vifor.
Each autumn, CSL sites across the Northern Hemisphere offer employees an opportunity to receive their annual flu shot.
To better understand how patients experience hereditary angioedema (HAE), CSL invited Anthony Castaldo and Henrik Boysen to m…
Iron deficiency is a significant global health problem and is recognized on November 26, which is Iron Deficiency Day. Learn …
Sharma is studying liver cancer cells as he pursues potential treatments via immunotherapy and vaccines.
Managing a chronic condition can put a squeeze on the time you have for creative pursuits. Get advice on how to leap into som…
CSL Behring leaders are helping shape the conversation in Europe about how to give patients access to potentially game-changi…
We asked those impacted by rare diseases to share their experiences and takeaways from the summit.
Americas
Asia Pacific
Middle East
Europe
